(Q43590223)

25 November 2017

title

Facilitation of latent inhibition by the atypical antipsychotic risperidone (English)

1 reference

25 November 2017

Alves CR

1

1 reference

25 November 2017

Silva MT

series ordinal

2

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

Pharmacology, Biochemistry and Behavior

25 November 2017

published in

1 reference

25 November 2017

volume

68

1 reference

25 November 2017

issue

3

1 reference

25 November 2017

page(s)

503-506

1 reference

Differential performance of acute and chronic schizophrenics in a latent inhibition task.

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900475-0

7 January 2021

Effects of antipsychotic drugs on latent inhibition: sensitivity and specificity of an animal behavioral model of clinical drug action.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900475-0

7 January 2021

The latent inhibition model of schizophrenic attention disorder. Haloperidol and sulpiride enhance rats' ability to ignore irrelevant stimuli.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900475-0

7 January 2021

Abolition of latent inhibition by a single 5 mg dose of d-amphetamine in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900475-0

7 January 2021

Disruption of latent inhibition in the rat by the 5-HT2 agonist DOI: effects of MDL 100,907, clozapine, risperidone and haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900475-0

7 January 2021

Effects of the neuroleptic alpha-flupenthixol on latent inhibition in aversively- and appetitively-motivated paradigms: evidence for dopamine-reinforcer interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900475-0

7 January 2021

A theory of attention: Variations in the associability of stimuli with reinforcement

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900475-0

7 January 2021

Reversal of amphetamine-induced behaviours by MDL 100,907, a selective 5-HT2A antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900475-0

7 January 2021

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900475-0

7 January 2021

Clozapine-induced potentiation of latent inhibition is due to its action in the conditioning stage: implications for the mechanism of action of antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900475-0

7 January 2021

The latent inhibition model dissociates between clozapine, haloperidol, and ritanserin.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900475-0

7 January 2021

Enhancement of latent inhibition in the rat by the atypical antipsychotic agent remoxipride.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900475-0

7 January 2021

Antagonism of amphetamine-induced disruption of latent inhibition in rats by haloperidol and ondansetron: implications for a possible antipsychotic action of ondansetron.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900475-0

7 January 2021

Neural substrates of latent inhibition: the switching model

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900475-0

7 January 2021

Facilitation of latent inhibition by haloperidol in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900475-0

7 January 2021

The switching model of latent inhibition: an update of neural substrates

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900475-0

7 January 2021

Disruption of latent inhibition by acute administration of low doses of amphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900475-0

7 January 2021

Haloperidol- and clozapine-induced enhancement of latent inhibition with extended conditioning: implications for the mechanism of action of neuroleptic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900475-0

7 January 2021

Haloperidol enhances latent inhibition in visual tasks in healthy people

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900475-0

7 January 2021

10.1016/S0091-3057(01)00475-0

Identifiers

DOI

1 reference

25 November 2017

1 reference